Long-Term Benefits of Leqembi for Alzheimer's Patients Revealed in Eisai Study
Tuesday, 30 July 2024, 21:09
Long-Term Efficacy of Leqembi
The Eisai study on the drug Leqembi highlights its continued benefits for patients diagnosed with Alzheimer's disease over a three-year span. Key findings include:
- Significant improvement in patient conditions during treatment
- Patients experience deterioration after stopping the therapy
Conclusion
These results suggest that ongoing treatment with Leqembi is crucial for managing Alzheimer's effectively.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.